Navigation Links
Drug Refused to Asbestos-Linked Cancer Patients

A body that is responsible for approving NHS treatments has been accused of placing money before patients//, after it blocked the usage of an anti-cancer drug.

The group analyzed the cost effectiveness of the drug, used to treat the cancer mesothelioma, and concluded that the drug would not be recommended for use except as part of ongoing or new.trial.

Mesothelioma is a kind of cancer that affects the lung lining and nine out of ten cases are due to exposure to asbestos. People who are involved in shipbuilding, railway engineering and asbestos product manufacturing are at an increased risk. . A cure for the disease is not available and pemetrexed disodium treatment is used to maintain the quality of life.

The makers of the drug, Eli Lilly, said it will appeal against the decision. Medical director of Lilly UK, Dr Joanna Nakielny, said: "This is a major blow for patients with mesothelioma, many of whom were unwittingly exposed to asbestos in their working lives making submarines, ships, boilers and trains”.

"This treatment does not save lives, but it can prolong the lives of patients and also improve the quality of the time they have left. Lilly will be formally appealing NICE’s decision." She added.


'"/>




Page: 1

Related medicine news :

1. Smoker Refused Treatment
2. Boy Refused Compensation For HIV Infection Following Hospital Admission
3. One in Ten NHS Dentists Refused To Sign the New Contract
4. Gardasil Refused Subsidy
5. NRI Fights for HIV Child Who was Refused Treatment
6. Fibroids unlikely to Turn Cancerous
7. Virus Level could Predict Cervical Cancer Risk
8. Cancer Doctors Okays Controversial Prostate Therapy
9. Potential New Cancer Gene Identified
10. Consensus on "Combination Therapy" for Breast Cancer
11. Cancers of Colon & Rectum linked to Cigarette Smoking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... and call tracking and monitoring solutions, announced today the launch of a redesigned ... a modern navigation and aesthetic, fully responsive design, and an enhanced search directory ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: